GNLX
Genelux
Stock NASDAQ – Stock Market Prices, News & Analysis
Entreprise biopharmaceutique développant des traitements d'immunothérapie contre le cancer à partir de virus oncolytiques.
$ 2.89
2.69 %
Genelux
$
2.89
2.69 %
GNLX
Entreprise biopharmaceutique développant des traitements d'immunothérapie contre le cancer à partir de virus oncolytiques.
Price history of Genelux
Price history of Genelux
Performance & Momentum
6 Months
20.60 %
1 Year
32.95 %
3 Years
76.88 %
5 Years
51.91 %
Momentum
79
Similar stocks to Genelux
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
